Schizophrenia & Other Psychotic Disorders
Out Of The Pipeline
Risperidone extended-release injectable suspension
RBP-7000 (Perseris) is the second long-acting injectable form of risperidone
approved in the United States.
Savvy Psychopharmacology
Catatonia: Recognition, management, and prevention of complications
Catatonia is associated with multiple medical complications that can result in death if unrecognized or unmanaged.
Commentary
Why is loxapine overlooked, underprescribed for psychosis?
Dr. Carl C. Bell says Dr. William Glazer was right to suggest that loxapine might act as an atypical antipsychotic agent – without the side...
Conference Coverage
Delusional infestation: not so rare
PARIS – Mayo Clinic study shows prevalence climbs sharply with advancing age.
Out Of The Pipeline
Aripiprazole lauroxil nanocrystal suspension
New long-acting injectable formulation simplifies the initiation regimen.
From the Journals
Schizophrenia patients not getting secondary cardiovascular prevention
The study authors called for patients with schizophrenia to be followed up during treatment and for an increase in treatment intensity after...
Curbside Consult
Chinese American man with high risk of psychosis
The patient intermittently hears voices of strangers in the background and is more depressed – with frequent crying episodes.
Latest News
Brain mapping takes next step toward precision psychiatry
MRI data show limited overlap in brain loci abnormalities among patients with the same disorder.
From the Journals
Inflammation in schizophrenia tied to poor functioning
Link suggests that targeting inflammation could help improve daily functioning in schizophrenia.
Evidence-Based Reviews
Antipsychotics for patients with dementia: The road less traveled
Second-generation agents have an important but limited role in treating behavioral and psychological symptoms.
Pearls
5 Strategies for managing antipsychotic-induced hyperprolactinemia
The relationship between antipsychotic treatment and hyperprolactinemia is well established.